FSLR
54
7
XYL
49
4
MPC
44
-3
EFX
38
2
XRAY
28
2
WDC
47
4
AMG
54
2
DFS
64
2
HPQ
63
6
PNC
64
4
PVH
62
5
NKE
36
6
HAS
33
3
PYPL
54
2
HON
67
2
CL
58
2
WEC
53
-2
BSX
67
-3
RIG
60
2
FE
50
-2
FSLR
54
7
XYL
49
4
MPC
44
-3
EFX
38
2
XRAY
28
2
WDC
47
4
AMG
54
2
DFS
64
2
HPQ
63
6
PNC
64
4
PVH
62
5
NKE
36
6
HAS
33
3
PYPL
54
2
HON
67
2
CL
58
2
WEC
53
-2
BSX
67
-3
RIG
60
2
FE
50
-2
Financhill
Back

ATAI Life Sciences NV 10K Form

Buy
63

ATAI
ATAI Life Sciences NV

Last Price:
1.61
Seasonality Move:
-7.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATAI News And Ratings

See the #1 stock for the next 7 days that we like better than ATAI

ATAI Financial Statistics

Sales & Book Value

Annual Sales: $314K
Cash Flow: $-19.34M
Price / Cash Flow: 0
Annual Sales: $0.87
Price / Book: 1.85

Profitability

EPS (TTM): -0.80000
Net Income (TTM): $-128.6M
Gross Margin: --
Return on Equity: -61.19%
Return on Assets: -50.08%

ATAI Life Sciences NV Earnings Forecast

Key ATAI Life Sciences NV Financial Ratios

  • The Research & Development expenses have been 19,809.87% of Revenue.
  • The Interest Expense is -6.60% of Operating Income.
  • The Net Earning history of ATAI is -12,810.19% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

ATAI Life Sciences NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ATAI
CUSIP: 00211V
Website: atai.life

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 5.81
Quick Ratio: 4.73

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATAI Technical Analysis vs Fundamental Analysis

Buy
63
ATAI Life Sciences NV (ATAI) is a Buy

Is ATAI Life Sciences NV a Buy or a Sell?